The global market for Cellular Health Testing is estimated at US$3.3 Billion in 2023 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 7.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Cellular Health Testing Market]( "Cellular Health Testing Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Single-Test Panels segment, which is expected to reach US$3.4 Billion by 2030 with a CAGR of 6.4%. The Multi-Test Panels segment is also set to grow at 8.9% CAGR over the next 8 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $978 Million in 2023, and China, forecasted to grow at an impressive 6.9% CAGR to reach $1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Cellular Health Testing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cellular Health Testing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Cellular Health Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Bio-Reference Laboratories, Inc., Cell Science Systems Corp., Cleveland Heartlab, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 22 Featured):
- Bio-Reference Laboratories, Inc.
- Cell Science Systems Corp.
- Cleveland Heartlab, Inc.
- Dna Labs India
- Genova Diagnostics
- Immundiagnostik AG
- Laboratory Corporation of America Holdings
- Life Length
- Quest Diagnostics, Inc.
- Repeat Diagnostics Inc. (Repeat Dx)
- Segterra, Inc.
- SpectraCell Laboratories, Inc.
- Telomere Diagnostics, Inc. (Tdx)
- Zimetry LLC
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Cellular Health Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Cellular Health Testing - Revolutionary Technology Provides Overview of Health at Cellular Level
- North America Projected to Retain Maximum Share in the Market
3. MARKET TRENDS & DRIVERS
- Rising Demand for Accurate Telomere Length Test Steers Market Growth
- Digital Transformation in Healthcare to Offer Significant Market Gains
- Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
- Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
- Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
- Percentage (In %) of Global Population Aged 65 and Above by Region
- US Population (In Million) Aged 65 and Above for the Years 2018, 2021, 2024, 2027, and 2030
- Government Policies and Measures Promoting Preventative Healthcare Augurs Well
- Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
- Global Precision Medicine Market (In US$ Billion) for the Years 2019, 2021, 2023, 2025 & 2027
- Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
- Key Challenges
- Limited Reimbursement
- Challenges in Sample Transportation
- Variation in Pricing of Test Kits
- COVID-19 Impact on Cellular Health Testing Market
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 19: World Cellular Health Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 20: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 21: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 22: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 23: World Recent Past, Current & Future Analysis for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 24: World Historic Review for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 25: World 16-Year Perspective for Other Collection Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 29: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 30: USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 31: USA 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 33: USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 34: USA 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
CANADA
- Table 35: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 36: Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 37: Canada 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 38: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: Canada 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 41: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: Canada 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
JAPAN
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 44: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Japan 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 47: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: Japan 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 50: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: Japan 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
CHINA
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 53: China Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 54: China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: China 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 56: China Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: China 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 59: China Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 60: China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: China 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
EUROPE
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 62: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 63: Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: Europe 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 65: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 66: Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 68: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 71: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
FRANCE
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 74: France Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: France 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 77: France Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: France 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 80: France Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: France 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
GERMANY
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 83: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: Germany 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 86: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: Germany 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 89: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: Germany 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
ITALY
- Table 92: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: Italy 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 95: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Italy 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 98: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Italy 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 101: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: UK 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 104: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 105: UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 106: UK 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 107: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 108: UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 109: UK 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 110: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 111: Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 112: Rest of Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 113: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 114: Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 115: Rest of Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 116: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 117: Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 118: Rest of Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 119: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 120: Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 121: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
- Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 123: Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 124: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
- Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 126: Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 127: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bio-Reference Laboratories, Inc.
- Cell Science Systems Corp.
- Cleveland Heartlab, Inc.
- Dna Labs India
- Genova Diagnostics
- Immundiagnostik AG
- Laboratory Corporation of America Holdings
- Life Length
- Quest Diagnostics, Inc.
- Repeat Diagnostics Inc. (Repeat Dx)
- Segterra, Inc.
- SpectraCell Laboratories, Inc.
- Telomere Diagnostics, Inc. (Tdx)
- Zimetry LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 184 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.3 Billion |
| Forecasted Market Value ( USD | $ 5.8 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
